Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Selectively Activating the Wnt Pathway to Target Specific Diseases with Craig Parker Surrozen TRANSCRIPT
Download PDFMar 29, 2022
Craig Parker is the CEO of Surrozen, experts in the Wnt pathway which is one of the fundamental pathways that help to establish the structure of organs, renewal of stem cells, and recovery from injury. This is a story of discovering the right combination of their tissue-specific approach and the right molecules to enhance or activate the Wnt pathway.
Craig elaborates, "So, in the liver, for example, when we injure our liver by drinking too much alcohol, the Wnt pathway is activated and is really the key pathway that's responsible for the regeneration that we're all able to stimulate in our liver."
"There are many, many other organs where the Wnt pathway is known to play a role in how that particular organ is maintained and responds to injury. So, what we're trying to do is take advantage of that biology that's so important in all of us during development and in adulthood and to stimulate it in a very selective way to get organs like the liver or the intestine or the retina to regenerate in response to the injury that certain diseases caused to that tissue."
"When you have biology that's so powerful, and that is so relevant in different organs, the challenge, really, probably the most fundamental challenge, is to utilize it or activate it only in the tissue that you want, only in the tissue that you're targeting for a specific disease. We don't want to activate this pathway throughout the body. So, it's that selective approach that really distinguishes our technology and our approach, and that was really an impediment to utilizing this pathway over the last 30 years."
#Surrozen #WntPathway #Wnt #WntBiology #WntSignaling #SevereAlcoholicHepatitis #LiverCells #IBD #TissueRepair #Biotech #FrizzledReceptors #ZincFIngers #ClinicalDevelopment
